Federal psilocybin rescheduling will not reach a floor vote this session.

A bill to change psilocybin's legal status at the federal level is very unlikely to get a full vote in Congress this session. The DEA (the agency that controls which drugs are illegal), the FDA, and most lawmakers aren't aligned enough to push it through. That means psilocybin stays a Schedule I drug federally — the same category as heroin — regardless of what individual states do.

Consensus of 3 agents: legislator, dea_officer, fda_reviewer. 1 dissenting.